Activation of mitogen-activated protein kinases is required for α1-adrenergic agonist-induced cell scattering in transfected HepG2 cells

Experimental Cell Research

Volumn 258, Issue 1, 2000, Pages 109-120

  Spector, Mark ^a   Nguyen, Van Anh ^a   Sheng, Xuening ^a   He, Liusheng ^b   Woodward, John ^a   Fan, Saijun ^c   Baumgarten, Clive M ^a   Kunos, George ^a   Dent, Paul ^a   Gao, Bin ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

AP1; Cell hypertrophy; Protein kinase C

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA 1 ADRENERGIC RECEPTOR; BISINDOLYLMALEIMIDE; CATECHOLAMINE; EPIDERMAL GROWTH FACTOR; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLEPHRINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; SCATTER FACTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; WORTMANNIN;

ADENOVIRUS; ARTICLE; CELL SPREADING; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ADENOVIRIDAE;

EID: 0034632055     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4907     Document Type: Article

References (53)

1. Graham R. M., Perez D. M., Hwa J., Piascik M. Alpha1-adrenergic receptor subtypes: Molecular structure, function, and signaling. Circ. Res. 78:1996;737-749.
2. 1-Adrenergic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 34:1994;117-133.
3. Simpson P. Stimulation of hypertrophy of cultured neonatal rat heart cells through an α1-adrenergic receptor and induction of beating through an α1- and β1-adrenergic receptor interaction: Evidence for independent regulation of growth and beating. Circ. Rec. 56:1985;884-894.
4. Knowlton K. U., Michel M. C., Itani M., Shubeita H. E., Ishihara K., Brown J. H., Chien K. R. The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J. Biol. Chem. 268:1993;15374-15380.
5. Michalopoulos G. K. Liver regeneration: Molecular mechanisms of growth control. FASEB J. 4:1990;176-187.
6. Cruise J. L., Knechtle S. J., Bollinger R. R., Kuhn C., Michalopoulos G. K. α1-Adrenergic effects and liver regeneration. Hepatology. 7:1987;1189-1194.
7. Cruise J. L., Houck K. A., Michalopoulos G. K. Induction of DNA synthesis in cultured rat hepatocytes through stimulation of α1 adrenergic receptor by norepinephrine. Science. 227:1985;749-751.
8. Spector M., Auer K., Jarvis W., Ishac E., Gao B., Kunos G., Dent P. Differential regulation of MAP and SAP kinase cascade by adrenergic agonists in quiescent and regenerating adult rat hepatocytes. Mol. Cell. Biol. 17:1997;3556-3565.
9. Auer K. L., Contessa J., Brenz-Verca S., Pirola L., Rusconi S., Cooper G., Abo A., Wymann M. P., Davis R., Birrer M., Dent P. The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Mol. Biol. Cell. 9:1998;561-573.
10. Thorburn J., McMahon M., Thorburn A. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J. Biol. Chem. 269:1994;30580-30586.
11. Bogoyevitch M. A., Glennon P. E., Sugden P. H. Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes. FEBS Lett. 317:1993;271-275.
12. Bogoyevitch M. A., Andersson M. B., Gillespie-Brown J., Clerk A., Glennon P. E., Fuller S. J., Sugden P. H. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem. J. 314:1996;115-121.
13. Gillespie-Brown J., Fuller S. J., Bogoyevitch M. A., Cowley S., Sugden P. H. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J. Biol. Chem. 270:1995;28092-28096.
14. Ramirez M. T., Sah V. P., Zhao X., Hunter J. J., Chien K. R., Brown J. H. The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J. Biol. Chem. 272:1997;14057-14061.
15. Zechner D., Thuerauf D. J., Hanford D. S., McDonough P. M., Glembotski C. A role for the p38 MAP kinase pathway in myocardial cell growth sarcomeric organization, and cardiac-specific gene expression. J. Cell Biol. 139:1997;115-127.
16. Hoshijima M., Sah V. P., Wang Y., Chien R., Brown J. H. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes: Involvement of Rho kinase. J. Biol. Chem. 273:1998;7725-7730.
17. Boluyt M. O., Zheng J. S., Younes A., Long X., O'Neill L., Silverman H., Lakatta E. G., Crow M. T. Rapamycin inhibits adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes: Evidence for involvement of p70 S6 kinase. Circ. Res. 81:1997;176-186.
18. q and α1-adrenergic receptor signaling in cardiomyocytes: Dissociation of Ras and Rho pathways. J. Biol. Chem. 271:1996;31185-31190.
19. Gottshall K. R., Hunter J. J., Tanaka N., Dalton N., Becker K. D., Ross J. Jr., Chien K. R. Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice. Proc. Natl. Acad. Sci. USA. 94:1997;4710-4715.
20. Hu Z. W., Shi X. Y., Lin R., Hoffman B. B. α1-Adrenergic receptors activate phosphatidylinositol 3 kinase in human vascular smooth muscle cells: Role in mitogenesis. J. Biol. Chem. 271:1996;8977-8982.
21. 1D-adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol. Pharmacol. 51:1997;764-775.
22. Allen L. F., Lefkowitz R. J., Caron M. G., Cotecchia S. G-protein-coupled receptor genes as protooncogenes: Constitutively activating mutation of the α1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc. Natl. Acad. Sci. USA. 88:1991;11354-11358.
23. 2-adrenergic receptors: Cellular mechanisms and physiological implications. Ann. N. Y. Acad. Sci. 757:1995;261-270.
24. 2-adrenergic receptors and gene transcripts in acutely isolated rat liver cells. J. Cell. Physiol. 152:1992;79-86.
25. 1-adrenergic receptor gene expression in regenerating liver. Mol. Cell. Biol. 16:1996;5997-6008.
26. Rossby S. P., Cornett L. E. Steady state levels of hepatic α1 and β2 adrenergic receptors and gene transcripts during development of the male rat. J. Cell. Physiol. 147:1991;55-61.
27. Bevilacqua M., Norbiato G., Chebat E., Baldi G., Bertora P., Regalia E., Colella G., Gennari L., Vago T. Changes in α1 and β2 adrenergic receptor density in human hepatocellular carcinoma. Cancer. 67:1991;2543-2551.
28. Kost D. P., DeFrances M. C., Lee C. R., Michalopoulos G. K. Patterns of α1 adrenergic receptor expression in regenerating and neoplastic hepatic tissue. Pathobiology. 60:1992;303-308.
29. Cip1/WAF1-dependent pathway. FEBS Lett. 436:1998;131-138.
30. Bae V. L., Jackson-Cook C. K., Maygarden S. J., Plymate S. R., Chen J., Ware J. L. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate. 34:1998;275-282.
31. Kunos H., Kan W. H., Greguski R., Venter J. G. Selective affinity labeling and molecular characterization of hepatic α1 adrenergic receptors with [3H]phenoxybenzamine. J. Biol. Chem. 258:1983;326-332.
32. Allgood V. E., Zhang Y., O'Malley B. W., Weigel N. L. Analysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high-efficiency DNA transfer. Biochemistry. 36:1997;224-232.
33. Nyugen V., Gao B. Cross-talk between α1 adrenergic receptor and interleukin 6 signaling pathways in hepatic cells: Activation of α1 adrenergic receptor inhibits interleukin 6-activated STAT3 by a p42/44 MAP kinase-dependent mechanism. J. Biol. Chem. 274:1999;35492-35498.
34. Jarvis W. D., Fornari F. A., Freemerman A. J., Szabo E., Martin H. A., Rao A. S., Birrer M. J., Barbour S. E., Dent P., Grant S. Differential requirement for c-Jun in the apoptotic actions of ceramide and sphingosine in human myeloid leukemia cells. Mol. Pharmacol. 52:1997;935-947.
35. Gao B., Spector M. S., Kunos G. The rat α1 adrenergic receptor gene middle promoter contains multiple binding sites for sequence-specific proteins including a novel ubiquitous transcription factor. J. Biol. Chem. 270:1995;5614-5619.
36. Potempa S., Ridley A. Activation of both MAP kinase and phosphatidylinositide 3 kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol. Biol. Cell. 9:1998;2185-2200.
37. Tseng-Crank J., Kost T., Goetz A., Hazum S., Roberson K. M., Haizlip J., Godinot N., Robertson C. N., Saussy D. The alpha 1C-adrenoceptor in human prostate: Cloning, functional expression, and localization to specific prostatic cell types. Br. J. Pharmacol. 115:1995;1475-1485.
38. Zhu X., Assoian R. K. Integrin-dependent activation of MAP kinase: A link to shape-dependent cell proliferation. Mol. Biol. Cell. 6:1995;273-282.
39. Tanimura S., Chatani Y., Hoshino R., Sato M., Watanabe S., Kataoka T., Nakamura T., Kohno M. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering. Oncogene. 17:1998;57-65.
40. Herrera R. Modulation of hepatocyte growth factor-induced scattering of HT29 colon carcinoma cells: Involvement of the MAPK pathway. J. Cell. Sci. 111:1998;1039-1049.
41. q-mediated pathways on calcium/calmodulin, pyk2 and Src kinase. J. Biol. Chem. 272:1997;19125-19132.
42. Nemoto S., Sheng Z., Lin A. Opposing effects of Jun kinase and p38 MAP kinases on cardiomyocyte hypertrophy. Mol. Cell. Biol. 18:1998;3518-3526.
43. Wang Y. B., Huang S., Sah V., Ross J., Brown J., Han J., Chien K. R. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 MAP kinase family. J. Biol. Chem. 273:1998;2161-2168.
44. Royal I., Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3 kinase. J. Biol. Chem. 270:1995;27780-27787.
45. Lakkakorpi P. T., Wesolowski G., Zimolo A., Rodan G. A., Rodan S. B. Phosphatidylinositide 3 kinase association with osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading. Exp. Cell Res. 237:1997;296-306.
46. Meng F., Lowell C. A. A β1 integrin signaling pathway involving Src-family kinases, Cb1 and PI3 kinase are required for macrophage spreading and migration. EMBO J. 17:1998;4391-4403.
47. 2+-independent, branch of the hepatic α1-adrenoreceptor signalling pathway. Biochem. J. 331:1998;89-97.
48. Chen L., Xin X., Eckhart A. D., Yang N., Faber J. E. Regulation of vascular smooth muscle growth by alpha 1-adrenoreceptor subtypes in vitro and in situ. J. Biol. Chem. 270:1995;30980-30988.
49. 2-, and β-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J. Biol. Chem. 273:1998;24624-24632.
50. Khwaja A., Lehmann K., Marte B. M., Downward J. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J. Biol. Chem. 273:1998;18793-18801.
51. Rong S., Bodescot M., Blair D., Dunn J., Nakamur T., Mizuno K., Park M., Chan A., Aaronson S., Vande Woude G. F. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Biol. Cell. 12:1992;5152-5158.
52. Bellusci S., Moens G., Gaudino G., Comoglio P., Nakamura T., Thierry J. P., Jouanneay J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorgenicity. Oncogene. 9:1994;1091-1099.
53. Agrawal D. K., Wildrick D. M., Boman B. M. Characteristics of alpha-adrenoceptors in two human colorectal cancer cell lines. Biochem. Biophys. Res. Commun. 185:1992;176-184.